INTRODUCTIONEczema affects approximately 31 million people in the United States and is characterized by dryness, itchiness, scaling, roughness, irritation, or discoloration as well as periodic unpredictable flares.1 Developing a good…
Read More
INTRODUCTIONAcne vulgaris is a common inflammatory cutaneous disorder of the pilosebaceous unit of the skin (comprising the hair follicle, hair shaft, and sebaceous gland), leading to the development of whiteheads,…
Read More
In this supplement: Brodalumab is an Efficacious, Safe, and Cost-Effective IL-17 Receptor Blocker for the Treatment of Moderate-to-Severe Plaque Psoriasis: 2023 UpdatePsoriasis remains a highly prevalent condition in the United…
Read More
INTRODUCTIONEczema- or atopy-prone skin frequently has an ineffective skin barrier, which can lead to redness, irritation, and dryness with periods of remission interspersed with flares.1 When their eczema flares, patients…
Read More
INTRODUCTIONThe underlying cause of Alzheimer's disease (AD), a progressive neurologic disorder that is the most common cause of dementia, is poorly understood. At present, the treatments currently available have limited…
Read More
INTRODUCTIONEczema, also called atopic dermatitis, is an inflammatory skin disease characterized by skin barrier damage, which translates to itch, dry skin, rash, scaling, blisters, and skin their eczema flares, patients…
Read More
INTRODUCTIONEczema, or atopic dermatitis (AD), is a common skin condition which is estimated to affect >31 million people in United States, with up to 25% of children and almost 10%…
Read More
introductionNemolizumab is a humanized monoclonal antibody directed against the interleukin (IL)-31 receptor alpha chain (IL-31RA) that blocks signaling from neuroimmune cytokine IL-31. While IL-31 was first thought to be primarily…
Read More
INTRODUCTIONPsoriasis is a significant health and economic burden. In the United States, the prevalence of psoriasis is estimated to be 7.4 million, which accounts for ~2.2% of the population, with…
Read More
INTRODUCTIONAtopic dermatitis (AD) is one of the most common inflammatory skin disorders. It is present in both the very young and the very old and is a significant cause of…
Read More
INTRODUCTIONTherapeutic Challenge How can we ensure dermatologists practice enhanced antibiotic stewardship to combat antimicrobial resistance and negative consequences of microbiome dysbiosis? Solution We developed a mnemonic ENLIGHTEN to help healthcare…
Read More
INTRODUCTIONLichen planus is an auto-inflammatory skin disorder marked by intensely pruritic, violaceous papules that commonly affect the extremities of middle-aged adults.1 Though a clear pathogenic mechanism remains unknown, some of…
Read More
